| TIME | NORTH BALLROOM |
|---|---|
| 07.30 - 08.30 | Opening Ceremony |
| SESSION 1 | Symposium 1 |
| NEUROVASCULAR and PAIN Current Understanding of Chronic Pain Syndromes After Ischemic Stroke | |
| 08.45 – 09.05 | Hyperuricemia Management in Patients with Cognitive Dysfunction |
| 09.05 – 09.25 | Efficacy and Safety of COX-2 Inhibitors in Patients after an Acute Stroke with Musculoskeletal Pain |
| 09.25 – 09.35 | Discussion |
| 09.35 - 09.40 | COFFEE BREAK |
| 09.40 - 10.10 | PLENNARY LECTURE I : Emerging Concept for Neuropathic Pain Treatment : from Pregabalin to Citicoline |
| 10.10 - 10.40 | PLENNARY LECTURE II : A Triple Combination of Anti-Parkinsonism for Stroke Patients with Parkinson |
| 10.40 - 11.10 | PLENNARY LECTURE III : Epilepsy |
| SESSION 2 | Symposium 2 |
| NEUROIMMUNOLOGY Comprehensive Management of Multiple Sclerosis | |
| 11.10 - 11.30 | Challenge in Multiple Sclerosis Management Based on Priority in Indonesia |
| 11.30 - 11.50 | Treatment of Multiple Sclerosis |
| 11.50 - 12.10 | Clinical Experience Treating Relapsing Multiple Sclerosis with Cladribrine; An Innovative Multiple Sclerosis Treatment |
| 12.10 - 12.15 | Discussion |
| 12.15 - 13.00 | LUNCH BREAK |
| SESSION 3 | Symposium 3 |
| NEUROBEHAVIOUR, NEURORESTORATION, AND PAIN Dementia and Neuroplasticity | |
| 13.00 - 13.20 | Emerging Therapies for Vascular Dementia |
| 13.20 - 13.40 | The Role of Combination of Choline Citrate, Cytidine Monophosphate and Phosphatidylserine for Neuroplasticity |
| 13.40 - 14.00 | Central Post-Stroke Pain |
| 14.00 - 14.05 | Discussion |
| SESSION 4 | Symposium 4 |
| NEUROPHYSIOLOGY AND PAIN Emerging Challenge and Advance in Polyneuropathy | |
| 14.05 - 14.25 | Basic and Pitfalls in Electromyography |
| 14.25 - 14.45 | Inflammatory Neuropathies |
| 14.45 - 15.05 | Management of Polyneuropathy |
| 15.05 - 15.15 | Discussion |